Le Lézard
Classified in: Health
Subject: PER

The Nature's Bounty Co. Names Mark Gelbert Chief Scientific Officer


RONKONKOMA, N.Y., Oct. 16, 2017 /PRNewswire/ -- The Nature's Bounty Co. today announced the appointment of Dr. Mark Gelbert to the position of Chief Scientific Officer. In this role, Dr. Gelbert will lead the company's research, development and innovation efforts by creating and executing product development strategies, enhancing product offerings, and driving product advancements across all of its global brands.

Dr. Mark Gelbert, Chief Scientific Officer, The Nature's Bounty Co.

With more than 30 years of experience in product development, Dr. Gelbert is a highly skilled executive leader in consumer healthcare innovation and brand development.  He has led the development and implementation of many new innovation cultures and is responsible for the launch of hundreds of new consumer drugs, dietary supplements and personal care products globally. Most recently, Mark was Senior Vice President of Global R&D and Switch for Pfizer Consumer Healthcare and a member of its Global Leadership Team.

"Mark's expertise and ability to turn scientific advances into market-leading products will be a tremendous asset to The Nature's Bounty Co. going forward," said Paul Sturman, President and Chief Executive Officer of The Nature's Bounty Co. "Investing in this part of our organization will bolster our ability to bring incredible new products to market to meet consumer needs."

"I am thrilled to be joining The Nature's Bounty Co. and energized by the incredible opportunities for innovation and creativity that are in front of us," said Dr. Gelbert. "Consumers are increasingly involved in their own healthcare decisions and solutions. Using research and science to drive new innovation allows us to meet those needs in creative, safe and effective ways."

Dr. Gelbert will begin his new role immediately and will be based in Ronkonkoma, NY. Dr. Gelbert holds a PhD in Chemistry from the University of Massachusetts, Amherst, a Juris Doctorate in Law from Northern Kentucky University, and a BA in Chemistry from Rutgers University. He has held leadership positions in a number of professional organizations including the Consumer Healthcare Products Association, where he was Chair of the Scientific Affairs Committee and a member of the Board of Directors.  Dr. Gelbert currently serves on the Rutgers University Chemistry and Chemical Biology Advisory Board.  He is admitted to the Ohio State Bar. 

About The Nature's Bounty Co.

The Nature's Bounty Co. has a history of championing health and wellness tracing back more than 70 years. Putting science and the highest quality standards at the heart of our business, the brands of The Nature's Bounty Co. are some of the most trusted in the world.  Always motivated by our commitment to excellence, our vision for health and wellness has inspired leading brands such as Nature's Bounty, Sundown Naturals, Solgar, Holland & Barrett, Osteo Bi-Flex, Ester-C, MET-Rx, Pure Protein, Balance, Body Fortress, Puritan's Pride and Organic Dr., among others. As a leading global manufacturer, marketer, distributor and retailer of vitamins, nutritional supplements, sports & active nutrition and ethical beauty products, The Nature's Bounty Co. is committed to supporting wellness in all its forms. For more information please visit: www.NaturesBountyCo.com.

Media Contacts:

The Nature's Bounty Co.
Jodi Katz
[email protected]
(631) 200-7491

SOURCE The Nature's Bounty Co.


These press releases may also interest you

at 11:50
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:30
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

at 11:15
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine. "The Effect of Open-Label Semaglutide on...

at 11:15
"My husband uses supplemental oxygen, and he needed a way to prevent continual kinks in the line," said an inventor, from Greenville, S.C., "so I invented the No Kink. My design helps provide continuous air flow, and it could also help prevent...

at 11:00
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has experienced a year of achievements across its three Centres of Excellence?Oncology, Genomics, and Transplantation. KFSH&RC's Oncology Centre of Excellence continues to lead the fight...

at 11:00
"I wanted to create a new type of mosquito repellant that can be worn on any area of the body to deter bites and irritation," said an inventor, from Waterbury, Conn., "so I invented the BYE BYE. My design enables you to enjoy a backyard party,...



News published on and distributed by: